Effect of AVACEN 100 on Brachial Artery Blood Flow

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04232111

Enrollment

Registered

2020-01-18

Start date

2020-02-01

Completion date

2020-06-01

Last updated

2025-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Flow

Brief summary

Determine effect of AVACEN 100 on brachial artery blood flow

Detailed description

Blood flow measured via ultrasound doppler

Interventions

DEVICEHeat

Heat applied to hand

DEVICEVacuum

vacuum applied to hand

DEVICEsham

neither heat nor vacuum

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Double-blind

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* anyone within specified age

Exclusion criteria

* anyone outside specified age

Design outcomes

Primary

Measure	Time frame
brachial artery blood flow via ultrasound doppler	10 min

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026